|Awarded On||August 19, 2020|
|Title||CPRIT RNA Therapeutics Core|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||The Methodist Hospital Research Institute|
|Principal Investigator/Program Director||John Cooke|
|Cancer Sites||All Sites|
*Pending contract negotiation
RNA Therapeutics is emerging as an exciting new class of drugs to defeat cancer. RNA is a form of biological software that can instruct a cell to make proteins that can protect against cancer. For example message RNA can be made that generates vaccines against cancer; or to modify white blood cells so that they will be more effective at destroying cancer; or to instruct cells to make proteins that stimulate an inflammatory response against cancer. The goal of this proposal is to expand our current CPRIT-funded RNAcore to create a state-of-the-art comprehensive CPRIT RNA Therapeutics facility that will help academic groups and biotechs in Texas and aid to translate their ideas and innovations...